• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6(IL-6)在肾细胞癌中作为一种体外自分泌生长因子发挥作用。

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas.

作者信息

Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T

机构信息

Third Department of Internal Medicine, Nissei Hospital, Osaka, Japan.

出版信息

FEBS Lett. 1989 Jul 3;250(2):607-10. doi: 10.1016/0014-5793(89)80805-1.

DOI:10.1016/0014-5793(89)80805-1
PMID:2787758
Abstract

Interleukin-6 (IL-6) was found to be a growth factor of renal cell carcinomas Furthermore, renal cell carcinomas freshly isolated from the patients expressed mRNA of IL-6 and secreted biologically active IL-6 under the culture conditions where the tumor cells could grow, but they did not produce IL-6 nor proliferate in the absence of fetal calf serum. The production of IL-6 by the tumor cells was also demonstrated by immunostaining of the IL-6-producing cells utilizing anti-IL-6 antiserum. Moreover, anti-IL-6 antiserum specifically inhibited the in vitro tumor growth. All data indicated that IL-6 functions as an in vitro autocrine growth factor of renal cell carcinomas.

摘要

白细胞介素-6(IL-6)被发现是肾细胞癌的一种生长因子。此外,从患者体内新鲜分离出的肾细胞癌在肿瘤细胞能够生长的培养条件下表达IL-6的mRNA并分泌具有生物活性的IL-6,但在没有胎牛血清的情况下,它们不产生IL-6也不增殖。利用抗IL-6抗血清对产生IL-6的细胞进行免疫染色也证实了肿瘤细胞产生IL-6。此外,抗IL-6抗血清特异性抑制体外肿瘤生长。所有数据表明,IL-6作为肾细胞癌的一种体外自分泌生长因子发挥作用。

相似文献

1
Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas.白细胞介素-6(IL-6)在肾细胞癌中作为一种体外自分泌生长因子发挥作用。
FEBS Lett. 1989 Jul 3;250(2):607-10. doi: 10.1016/0014-5793(89)80805-1.
2
IL-6 as an intracrine growth factor for renal carcinoma cell lines.白细胞介素-6作为肾癌细胞系的自分泌生长因子。
Int J Cancer. 2004 Sep 20;111(5):653-61. doi: 10.1002/ijc.20287.
3
Inhibitory effect of dexamethasone and progesterone in vitro on proliferation of human renal cell carcinomas and effects on expression of interleukin-6 or interleukin-6 receptor.
J Urol. 1995 Mar;153(3 Pt 1):858-62.
4
[Anti-interleukin-6 (IL-6) therapy of IL-6-producing renal cell carcinoma].
Hinyokika Kiyo. 1992 Nov;38(11):1333-6.
5
Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line.
J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):462-7. doi: 10.1111/j.1440-1746.1994.tb01275.x.
6
A possible autocrine role for interleukin-6 in two lymphoma cell lines.
Blood. 1989 Aug 1;74(2):798-804.
7
[Significance of oncogenes and growth factors in hypernephroma].
Urologe A. 1992 Jan;31(1):24-7.
8
Analysis of growth factors in renal cell carcinoma.
Biochem Biophys Res Commun. 1988 Jun 16;153(2):818-24. doi: 10.1016/s0006-291x(88)81169-0.
9
A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitor.肾细胞癌产生的白细胞介素6信使核糖核酸的一种剪接异构体编码一种白细胞介素6抑制剂。
Cancer Res. 2005 Jan 1;65(1):2-5.
10
Expression of scavenger receptors on renal cell carcinoma cells in vitro.
Biochem Biophys Res Commun. 1992 Dec 30;189(3):1323-8. doi: 10.1016/0006-291x(92)90218-a.

引用本文的文献

1
A case report of metastatic renal cell carcinoma and ANCA associated vasculitis.转移性肾细胞癌与抗中性粒细胞胞浆抗体相关性血管炎的病例报告
BMC Nephrol. 2025 Jul 3;26(1):345. doi: 10.1186/s12882-025-04247-4.
2
Advancing cancer cachexia diagnosis with -omics technology and exercise as molecular medicine.利用组学技术和运动作为分子医学推进癌症恶病质的诊断
Sports Med Health Sci. 2024 Jan 28;6(1):1-15. doi: 10.1016/j.smhs.2024.01.006. eCollection 2024 Mar.
3
Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors.
一线免疫检查点抑制剂治疗转移性肾细胞癌患者的真实世界队列中,C 反应蛋白早期动力学作为生存预后标志物。
Clin Transl Oncol. 2024 May;26(5):1117-1128. doi: 10.1007/s12094-023-03317-z. Epub 2023 Sep 11.
4
Novel Biomarkers for Atherosclerotic Disease: Advances in Cardiovascular Risk Assessment.动脉粥样硬化疾病的新型生物标志物:心血管风险评估的进展
Life (Basel). 2023 Jul 27;13(8):1639. doi: 10.3390/life13081639.
5
Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101.C 反应蛋白与avelumab 联合 axitinib 治疗晚期肾细胞癌疗效的相关性:JAVELIN Renal 101 的长期随访结果。
ESMO Open. 2022 Oct;7(5):100564. doi: 10.1016/j.esmoop.2022.100564. Epub 2022 Aug 28.
6
SIGIRR Downregulation and Interleukin-1 Signaling Intrinsic to Renal Cell Carcinoma.信号抑制因子(SIGIRR)下调与肾细胞癌内在的白细胞介素-1信号传导
Front Oncol. 2022 Jun 22;12:894413. doi: 10.3389/fonc.2022.894413. eCollection 2022.
7
Advanced systemic amyloidosis secondary to metastatic renal cell carcinoma.继发于转移性肾细胞癌的晚期系统性淀粉样变性。
Ecancermedicalscience. 2020 Dec 15;14:1156. doi: 10.3332/ecancer.2020.1156. eCollection 2020.
8
Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review).癌症恶病质导致肌肉萎缩的分子机制(综述)。
Mol Med Rep. 2020 Dec;22(6):4967-4980. doi: 10.3892/mmr.2020.11608. Epub 2020 Oct 16.
9
Association of inflammatory biomarkers with lung cancer in North Indian population.北印度人群中炎症生物标志物与肺癌的关联
Afr Health Sci. 2019 Jun;19(2):2147-2155. doi: 10.4314/ahs.v19i2.39.
10
IL-6 Activities in the Tumour Microenvironment. Part 1.肿瘤微环境中的白细胞介素-6活性。第1部分。
Open Access Maced J Med Sci. 2019 Jul 20;7(14):2391-2398. doi: 10.3889/oamjms.2019.589. eCollection 2019 Jul 30.